Form 4: VTV Therapeutics Director Anne M. Phillips Reports Stock Option Grant
SEC Form 4 Filing
Director Anne M. Phillips reports the acquisition of stock options in VTV Therapeutics Inc.
Summary
- Anne M. Phillips, a director of vTv Therapeutics Inc., reported changes in beneficial ownership.
- On June 25, 2024, Phillips acquired stock options to purchase 2,250 shares of Class A Common Stock at an exercise price of $17.22, vesting monthly over three years.
- Phillips also acquired stock options to purchase 860 shares of Class A Common Stock at an exercise price of $17.22, vesting in full on June 25, 2025.
- Following these transactions, Phillips directly owns 6,860 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock option grants to a director. It doesn't inherently indicate positive or negative performance, but rather provides transparency.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- Shareholders are informed about changes in beneficial ownership by a company director.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of stock option grant and earliest transaction. |
| 06/25/2025 | Date of full vesting for 860 stock options. |
| 06/25/2034 | Expiration date for the stock options. |
| 06/27/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.